Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host interactions

Inflammatory Bowel Diseases

Volumn 18, Issue 5, 2012, Pages 943-954

  Büchler, Gwen ^a   Wos Oxley, Melissa L ^b   Smoczek, Anna ^a   Zschemisch, Nils H ^a   Neumann, Detlef ^a   Pieper, Dietmar H ^b   Hedrich, Hans J ^a   Bleich, Andre ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Animal model of IBD; Experimental colitis; Helicobacter hepaticus; Microbiology of IBD; Microflora

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; CECUM; CLOSTRIDIUM; CLOSTRIDIUM LEPTUM; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE LOCUS; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFLAMMATION; INOCULATION; INTESTINE FLORA; LACTOBACILLUS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECIES DIVERSITY; SPECIES RICHNESS; STRAIN DIFFERENCE;

ANIMALS; COLITIS; COLON; CYTOKINES; DISEASE SUSCEPTIBILITY; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL TRACT; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; INFLAMMATION; INTERLEUKIN-10; MALE; METAGENOME; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SPECIES SPECIFICITY;

EID: 84859786782     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21895     Document Type: Article

References (50)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429. (Pubitemid 34851835)
2. Bleich A, Mähler M. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and Helicobacter-induced gastritis. Pathobiology. 2005;72:293-307.
3. Kühn R, Löhler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274. (Pubitemid 23320290)
4. Farmer MA, Sundberg JP, Bristol IJ, et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A. 2001;98:13820-13825. (Pubitemid 33115982)
5. Mähler M, Most C, Schmidtke S, et al. Genetics of colitis susceptibility in IL-10-deficient mice: backcross versus F2 results contrasted by principal component analysis. Genomics. 2002;80:274-282. (Pubitemid 34985017)
6. Bleich A, Mähler M, Most C, et al. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome. 2004;15:865-871. (Pubitemid 40064197)
7. Borm ME, He J, Kelsall B, et al. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models. Gastroenterology. 2005;128:74-85. (Pubitemid 40039960)
8. Ermann J, Garrett WS, Kuchroo J, et al. Severity of innate immune-mediated colitis is controlled by the cytokine deficiency-induced colitis susceptibility-1 (Cdcs1) locus. Proc Natl Acad Sci U S A. 2011;108:7137-7141.
9. Beckwith J, Cong Y, Sundberg JP, et al. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology. 2005;129:1473-1484. (Pubitemid 41597390)
10. Bleich A, Büchler G, Beckwith J, et al. Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity. Inflamm Bowel Dis. 2010;16:765-775.
11. de Buhr MF, Mähler M, Geffers R, et al. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics. 2006;25:426-434. (Pubitemid 43764764)
12. Mähler M, Leiter EH. Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm Bowel Dis. 2002;8:347-355.
13. Burich A, Hershberg R, Waggie K, et al. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2001;281:G764-778.
14. Kullberg MC, Ward JM, Gorelick PL, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun. 1998;66:5157-5166. (Pubitemid 29044604)
15. Nicklas W, Baneux P, Boot R, et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim. 2002;36:20-42. (Pubitemid 34073119)
16. Whary MT, Fox JG. Natural and experimental Helicobacter infections. Comp Med. 2004;54:128-158. (Pubitemid 38590829)
17. Sterzenbach T. Untersuchungen zur Pathogenität von Helicobacter hepaticus: genomische und funktionelle Aspekte. Institut für Hygiene und Mikrobiologie. Würzburg, Germany: Bayerische Julius-Maximilian- Universität; 2006.
18. Suerbaum S, Josenhans C, Sterzenbach T, et al. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A. 2003;100:7901-7906. (Pubitemid 36760067)
19. Riley LK, Franklin CL, Hook RR Jr, et al. Identification of murine helicobacters by PCR and restriction enzyme analyses. J Clin Microbiol. 1996;34:942-946. (Pubitemid 26091512)
20. Shames B, Fox JG, Dewhirst F, et al. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J Clin Microbiol. 1995;33:2968-2972.
21. Mähler M, Bedigian HG, Burgett BL, et al. Comparison of four diagnostic methods for detection of Helicobacter species in laboratory mice. Lab Anim Sci. 1998;48:85-91. (Pubitemid 128521104)
22. Bleich A, Janus LM, Smoczek A, et al. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology. 2009;136:278-287.
23. Neumann D, Tschernig T, Popa D, et al. Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms. Int Immunol. 2006;18:1779-1787. (Pubitemid 44884040)
24. Jurisic G, Sundberg JP, Bleich A, et al. Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease. Genes Immun. 2010;11:219-231.
25. Madsen KL, Doyle JS, Jewell LD, et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999;116:1107-1114. (Pubitemid 29203020)
26. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121:580-591. (Pubitemid 32822573)
27. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10- deficient mice. Inflamm Bowel Dis. 2002;8:71-80. (Pubitemid 34213503)
28. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003;52:975-980. (Pubitemid 36765289)
29. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. 2002;160:2253-2257. (Pubitemid 34663415)
30. Dieleman LA, Arends A, Tonkonogy SL, et al. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun. 2000;68:5107-5113.
31. Sundberg JP, Elson CO, Bedigian H, et al. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology. 1994;107:1726-1735. (Pubitemid 24357626)
32. Sterzenbach T, Lee SK, Brenneke B, et al. Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells. Infect Immun. 2007;75:2717-2728. (Pubitemid 46870152)
33. Kleinschek MA, Boniface K, Sadekova S, et al. Circulating and gutresident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med. 2009;206:525-534.
34. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52:65-70. (Pubitemid 36020767)
35. Sarra M, Pallone F, Macdonald TT, et al. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis. 2010;16:1808-1813.
36. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006;116:1310-1316.
37. Kullberg MC, Jankovic D, Feng CG, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006;203:2485-2494. (Pubitemid 44664618)
38. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104: 13780-13785. (Pubitemid 350003397)
39. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
40. Ott SJ, Plamondon S, Hart A, et al. Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse. J Clin Microbiol. 2008;46:3510-3513.
41. Lupp C, Robertson ML, Wickham ME, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe. 2007;2:119-129. (Pubitemid 47209521)
42. Kuehl CJ, Wood HD, Marsh TL, et al. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun. 2005;73:6952-6961. (Pubitemid 41368864)
43. Ge Z, Feng Y, Taylor NS, et al. Colonization dynamics of altered Schaedler flora is influenced by gender, aging, and Helicobacter hepaticus infection in the intestines of Swiss Webster mice. Appl Environ Microbiol. 2006;72:5100-5103. (Pubitemid 44078848)
44. Chan V, Crocetti G, Grehan M, et al. Visualization of Helicobacter species within the murine cecal mucosa using specific fluorescence in situ hybridization. Helicobacter. 2005;10:114-124. (Pubitemid 40477019)
45. Sarma-Rupavtarm RB, Ge Z, Schauer DB, et al. Spatial distribution and stability of the eight microbial species of the altered Schaedler flora in the mouse gastrointestinal tract. Appl Environ Microbiol. 2004;70:2791-2800. (Pubitemid 38657794)
46. Pena JA, Rogers AB, Ge Z, et al. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun. 2005;73:912-920. (Pubitemid 40165750)
47. Hufeldt MR, Nielsen DS, Vogensen FK, et al. Family relationship of female breeders reduce the systematic inter-individual variation in the gut microbiota of inbred laboratory mice. Lab Anim. 2010;44:283-289.
48. Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun. 1999;67:2969-2974. (Pubitemid 29244716)
49. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945-953. (Pubitemid 26293312)
50. Bloom SM, Bijanki VN, Nava GM, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. 2010;9:390-403.